Research workbench
Discovery of cytotoxic dolastatin 10 analogs with N-terminal modifications
Analyse Discovery of cytotoxic dolastatin 10 analogs with N-terminal modifications in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 4X20
- Type
- protein
- Length
- 1,840 residues
- Chains
- 5
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Tubulin alpha chain; Tubulin beta chain; Stathmin-4
- UniProt
- D0VWZ0, D0VWY9, P63043
- Ligands
- GTP, GDP, LOC, 3WY, MG
- Pockets
- 20 · best druggability 0.85
Structure
x-ray diffraction · 5 distinct chains · 47% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Tubulin alpha chain | protein | 429 | 44% helix, 16% strand | D0VWZ0 |
| B | Tubulin beta chain | protein | 428 | 48% helix, 17% strand | D0VWY9 |
| C | Tubulin alpha chain | protein | 430 | 43% helix, 17% strand | D0VWZ0 |
| D | Tubulin beta chain | protein | 430 | 47% helix, 17% strand | D0VWY9 |
| E | Stathmin-4 | protein | 123 | 76% helix, 10% strand | P63043 |
Ligands and binding sites
- GTP · Guanosine-5'-triphosphate · ligand · 2 copies · chains A, B, C, D
- GDP · Guanosine-5'-diphosphate · ligand · 2 copies · chains B, D
- LOC · N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[d]heptalen-7-yl]ethanamide · ligand · 2 copies · chains A, B, C, D
- 3WY · 2-methyl-L-prolyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide · ligand · 2 copies · chains B, C, D
- MG · Magnesium ion · metal · 2 copies · chains A, B, C, D
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
20 pockets found on a 1 Å grid, 13 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1130 | 0.85 | 0.86 | 115 | GTP, MG, LOC |
| 2 | 870 | 0.83 | 0.85 | 90 | GTP, MG, LOC |
| 3 | 1006 | 0.81 | 0.82 | 109 | GDP, 3WY |
| 4 | 456 | 0.72 | 0.82 | 48 | empty |
| 5 | 383 | 0.66 | 0.80 | 47 | empty |
Interfaces
7 interfaces between chains.
- A–E · 1711 Ų buried · 29 hydrogen bonds · protein-protein
- A–B · 1386 Ų buried · 17 hydrogen bonds · protein-protein
- C–D · 1329 Ų buried · 18 hydrogen bonds · protein-protein
- B–C · 861 Ų buried · 13 hydrogen bonds · protein-protein
- C–E · 789 Ų buried · 6 hydrogen bonds · protein-protein
Compared structures
- 4X20 · Discovery of cytotoxic Dolastatin 10 analogs with N-terminal modifications · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt D0VWZ0
- Every structure of UniProt D0VWY9
- Every structure of UniProt P63043
- Elsewhere: RCSB PDB 4X20 · PDBe 4X20 · UniProt D0VWZ0 · UniProt D0VWY9 · UniProt P63043
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.